You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ruxolitinib

Showing 51 - 75 of 345
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Minneapolis, Minnesota
  • +2 more
Nov 2, 2022

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Ruxolitinib
  • +5 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 16, 2023

Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Ruxolitinib
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 25, 2022

Myelofibrosis Trial in Paris (Ruxolotinib)

Completed
  • Myelofibrosis
  • Paris, France
    ROBIN
Jul 26, 2022

Necrobiosis Lipoidica Trial in Scottsdale (Ruxolitinib)

Completed
  • Necrobiosis Lipoidica
  • Ruxolitinib
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Mar 17, 2022

Myelofibrosis Trial in Hong Kong (Bomedemstat)

Recruiting
  • Myelofibrosis
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Oct 3, 2022

Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Ruxolitinib
  • +2 more
  • Phoenix, Arizona
  • +9 more
Jan 9, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation Trial in United States

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Ruxolitinib
  • Boston, Massachusetts
  • +5 more
Oct 21, 2022

Myelofibrosis Trial in Coral Gables, Tampa, New York (Imetelstat, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Coral Gables, Florida
  • +2 more
Jul 12, 2022

Ruxolitinib for Polycythemia Vera in Patients Resistant to or

Completed
  • Polycythemia Vera (PV)
  • Ruxolitinib
  • East Hanover, New Jersey
    Novartis Investigative Site
Jun 29, 2022

Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Advanced Cutaneous Squamous Cell Carcinoma Trial in Atlanta, Chicago, New York (Ruxolitinib)

Recruiting
  • Advanced Cutaneous Squamous Cell Carcinoma
  • Ruxolitinib
  • Atlanta, Georgia
  • +2 more
Jun 28, 2022

Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Bone
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 4, 2023

Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)

Active, not recruiting
  • Myelofibrosis
  • Middletown, New Jersey
  • +6 more
Aug 23, 2022

Cutaneous Lichen Planus Trial in Canada, United States (Ruxolitinib cream, Vehicle cream)

Recruiting
  • Cutaneous Lichen Planus
  • Ruxolitinib cream
  • Vehicle cream
  • Birmingham, Alabama
  • +6 more
Dec 1, 2022

Polycythemia Vera Trial (Ruxolitinib)

Available
  • Polycythemia Vera
  • Ruxolitinib
  • (no location specified)
Mar 7, 2022

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced), Alopecia Areata Trial run by the National Institute of

Recruiting
  • Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)
  • Alopecia Areata
  • Ruxolitinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Macrophage Activation Syndrome Trial (Ruxolitinib, methylprednisolone)

Not yet recruiting
  • Macrophage Activation Syndrome
  • (no location specified)
Mar 16, 2022

aGVHD, Stem Cell Transplant Complications Trial in Beijing (Ruxolitinib 10 mg twice a day combined with Corticosteroids,

Completed
  • aGVHD
  • Stem Cell Transplant Complications
  • Ruxolitinib 10 mg twice a day combined with Corticosteroids
  • +3 more
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 12, 2021

Coronavirus Infection Trial in Madrid (Ruxolitinib plus simvastatin, Standard of Care)

Completed
  • Coronavirus Infection
  • Ruxolitinib plus simvastatin
  • Standard of Care
  • Madrid, Spain
    Hospital Universitario Madrid Sanchinarro
Jun 3, 2022

Blasts More Than 20 Percent of Bone Marrow Nucleated Cells, Blasts More Than 20 Percent of Peripheral Blood White Cells,

Completed
Has Results
  • Blasts More Than 20 Percent of Bone Marrow Nucleated Cells
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Lymphoma Trial in United States (Ruxolitinib)

Recruiting
  • Lymphoma
  • Ruxolitinib
  • Miami, Florida
  • +9 more
Oct 5, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Columbus, Ohio
  • +2 more
Aug 10, 2022

Psoriasis Trial in United States (Ruxolitinib phosphate cream, Dovonex® calcipotriene 0.005%, Diprolene® AF betamethasone

Completed
Has Results
  • Psoriasis
  • Ruxolitinib phosphate cream
  • +3 more
  • Vallejo, California
  • +5 more
Feb 7, 2022

Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease, Solid Organ Transplant Trial in Cincinnati (Ruxolitinib)

Recruiting
  • Acute-graft-versus-host Disease
  • +2 more
  • Ruxolitinib
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 31, 2022